BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013

Jul 24, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-07-22

Reporting Person: Cohen Fred E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-22	Non-Qualified Stock Option	$3.72	A	20833	Acquired	2023-07-22	Common Stock (20833)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: Vest 1/10 per month over 10 months beginning August 22, 2013.